|drug3687||azoximer bromide Wiki||1.00|
There is one clinical trial.
Since the outbreak of coronavirusdisease2019(COVID-19), many researchers in China have carried out/published clinical trials on treatment based on Western medicine, traditional Chinese medicine or a combination of the two. Trials on treatment modalities have mainly used antivirals, interferon, glucocorticoids in addition to traditional Chinese medicine. There are also clinical trials exploring hydroxyquinoline/chloroquine sulphate, immunoglobulins, Vitamin-C, washed microbiota, nebulized interferon, teicoplanin as well as Mesenchymal stem cells. However, most of these trials were small (median sample size 100) and the bulk of potential therapeutic strategies remain in the experimental phase and currently there is no eﬀective speciﬁc antiviral with high-level evidence.The aim of this study is assess the efficacy of MSCs as an add-on therapy to standard supportive treatment for patients with moderate/severe COVID-19.
Description: Assessment of Overall survival at 30 days post interventionMeasure: Overall survival Time: 30 days post intervention
Description: days required for oxygen support independence after interventionMeasure: Clinical improvement Time: 30 days
Description: PCR testing to check PCR negativityMeasure: Time of COVID19 PCR negativity Time: day 1,3,7,10, 14
Description: Computed tomography Chest assesment will be done to assess improvment in radiological findings of COVID-19Measure: Radiological improvement (day 15 and day 30 assessment) Time: day 15 and day30
Description: number of days required for discharge from hospitalMeasure: days required to discharge from hospital Time: 30 days post admission
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports